Effect of mexiletine on sea anemone toxin-induced non-inactivating sodium channels of rat skeletal muscle: a model of sodium channel myotonia

被引:9
作者
Desaphy, JF
Camerino, DC
Tortorella, V
De Luca, A
机构
[1] Fac Farm, Unita Farmacol, Diptartimento Farmacobiol, I-70125 Bari, Italy
[2] Fac Farm, Dipartimento Farmacochim, Bari, Italy
关键词
sodium channel; myotonia; skeletal muscle; ATX II; mexiletine;
D O I
10.1016/S0960-8966(98)00115-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The sea anemone toxin ATX II impairs skeletal muscle sodium channel inactivation, mimicking the persistent inward current observed in patients suffering from sodium channel myotonia. Mexiletine has beneficial effects on myotonia. To verify the efficiency of the drug on persistent inward current, we investigated the effect of 50 mu M R(-)-mexiletine on sodium channels in cell-attached parches of rat skeletal muscle fibres, in the absence or presence of 2 mu M ATX II. With the toxin, a proportion of channels displayed remarkable abnormal activity lasting the entire depolarisation, which resulted in a persistent inward current that represented up to 2.0% of the peak current. Mexiletine reduced by 75% the peak current elicited by depolarisation from -100 to -20 mV. This was due to the reduction by 60% of the maximal available peak current I-max and to the negative shift by -7 mV of steady-state inactivation. Mexiletine also greatly decreased the late current, but the effect was limited to 60% of reduction, comparable to that on I-max. Therefore mexiletine was able to block the ATX II-modified sodium channels, inhibiting the myotonia-producing persistent inward current. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:182 / 189
页数:8
相关论文
共 28 条
  • [1] Lidocaine block of LQT-3 mutant human Na+ channels
    An, RH
    Bangalore, R
    Rosero, SZ
    Kass, RS
    [J]. CIRCULATION RESEARCH, 1996, 79 (01) : 103 - 108
  • [2] CANNON SC, 1993, J PHYSIOL-LONDON, V466, P501
  • [3] FUNCTIONAL EXPRESSION OF SODIUM-CHANNEL MUTATIONS IDENTIFIED IN FAMILIES WITH PERIODIC PARALYSIS
    CANNON, SC
    STRITTMATTER, SM
    [J]. NEURON, 1993, 10 (02) : 317 - 326
  • [4] From mutation to myotonia in sodium channel disorders
    Cannon, SC
    [J]. NEUROMUSCULAR DISORDERS, 1997, 7 (04) : 241 - 249
  • [5] CATTERALL WA, 1981, MOL PHARMACOL, V20, P356
  • [6] Sea anemone toxin (ATX II) modulation of heart and skeletal muscle sodium channel alpha-subunits expressed in tsA201 cells
    Chahine, M
    Plante, E
    Kallen, RG
    [J]. JOURNAL OF MEMBRANE BIOLOGY, 1996, 152 (01) : 39 - 48
  • [7] Colquhoun Colquhoun D. D., SINGLE CHANNEL RECOR, P191
  • [8] FUNCTIONAL CONSEQUENCES OF A NA+ CHANNEL MUTATION CAUSING HYPERKALEMIC PERIODIC PARALYSIS
    CUMMINS, TR
    ZHOU, JY
    SIGWORTH, FJ
    UKOMADU, C
    STEPHAN, M
    PTACEK, LJ
    AGNEW, WS
    [J]. NEURON, 1993, 10 (04) : 667 - 678
  • [9] Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide
    De Luca, A
    Natuzzi, F
    Falcone, G
    Duranti, A
    Lentini, G
    Franchini, C
    Tortorella, V
    Camerino, DC
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (06) : 777 - 787
  • [10] DeLuca A, 1997, J PHARMACOL EXP THER, V282, P93